Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29026 - 29050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	CRYAB	1410	upregulated	Dasatinib results in increased expression of CRYAB mRNA	11q23.1	A21899
Dasatinib	Approved Investigational	CXCL10	3627	upregulated	Dasatinib results in increased expression of CXCL10 mRNA	4q21.1	A21901
Dasatinib	Approved Investigational	CYP1B1	1545	upregulated	Dasatinib results in increased expression of CYP1B1 mRNA	2p22.2	A21899
Dasatinib	Approved Investigational	DACT1	51339	upregulated	Dasatinib results in increased expression of DACT1 mRNA	14q23.1	A21899
Dasatinib	Approved Investigational	DCBLD2	131566	downregulated	Dasatinib results in decreased expression of DCBLD2 mRNA	3q12.1	A21899
Dasatinib	Approved Investigational	DDIAS	220042	downregulated	Dasatinib results in decreased expression of DDIAS mRNA	11q14.1	A21899
Dasatinib	Approved Investigational	DDIT4	54541	upregulated	Dasatinib results in increased expression of DDIT4 mRNA	10q22.1	A21899
Dasatinib	Approved Investigational	DEPDC1	55635	downregulated	Dasatinib results in decreased expression of DEPDC1 mRNA	1p31.3	A21899
Dasatinib	Approved Investigational	DEPDC1B	55789	downregulated	Dasatinib results in decreased expression of DEPDC1B mRNA	5q12.1	A21899
Dasatinib	Approved Investigational	DHFR	1719	downregulated	Dasatinib results in decreased expression of DHFR mRNA	5q14.1	A21899
Dasatinib	Approved Investigational	DHRS3	9249	upregulated	Dasatinib results in increased expression of DHRS3 mRNA	1p36.21	A21899
Dasatinib	Approved Investigational	DIAPH3	81624	downregulated	Dasatinib results in decreased expression of DIAPH3 mRNA	13q21.2	A21899
Dasatinib	Approved Investigational	DKK1	22943	downregulated	Dasatinib results in decreased expression of DKK1 mRNA	10q21.1	A21899
Dasatinib	Approved Investigational	DLEU2	8847	downregulated	Dasatinib results in decreased expression of DLEU2 mRNA	13q14.2	A21899
Dasatinib	Approved Investigational	DLGAP5	9787	downregulated	Dasatinib results in decreased expression of DLGAP5 mRNA	14q22.3	A21899
Dasatinib	Approved Investigational	DNA2	1763	downregulated	Dasatinib results in decreased expression of DNA2 mRNA	10q21.3	A21899
Dasatinib	Approved Investigational	DPP4	1803	upregulated	Dasatinib results in increased expression of DPP4 mRNA	2q24.2	A21899
Dasatinib	Approved Investigational	DSN1	79980	downregulated	Dasatinib results in decreased expression of DSN1 mRNA	20q11.23	A21899
Dasatinib	Approved Investigational	DTL	51514	downregulated	Dasatinib results in decreased expression of DTL mRNA	1q32.3	A21899
Dasatinib	Approved Investigational	E2F7	144455	downregulated	Dasatinib results in decreased expression of E2F7 mRNA	12q21.2	A21899
Dasatinib	Approved Investigational	ECH1	1891	upregulated	Dasatinib results in increased expression of ECH1 mRNA	19q13.2	A21899
Dasatinib	Approved Investigational	ECT2	1894	downregulated	Dasatinib results in decreased expression of ECT2 mRNA	3q26.31	A21899
Dasatinib	Approved Investigational	EDIL3	10085	upregulated	Dasatinib results in increased expression of EDIL3 mRNA	5q14.3	A21899
Dasatinib	Approved Investigational	EFEMP1	2202	upregulated	Dasatinib results in increased expression of EFEMP1 mRNA	2p16.1	A21899
Dasatinib	Approved Investigational	ELN	2006	upregulated	Dasatinib results in increased expression of ELN mRNA	7q11.23	A21899

Displaying entries 29026 - 29050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability